Login

Ingredients

Magnesium

A mineral with respectable evidence for blood pressure in the people who are already hypertensive or low in it, weak evidence for sleep, and a clear negative result for the leg cramps it is most often sold to treat 12.

Last scientifically reviewed: November 22, 2026Editorial review: MDS Labs. External scientific review pending.

Commercial disclosure. MDS Labs sells a magnesium glycinate supplement. Everything on this page applies to it, including the Cochrane finding on cramps.

Common names
Magnesium; on labels magnesium glycinate, citrate, oxide, malate, threonate or chloride
Source
Diet: green leafy vegetables, nuts, seeds, legumes and whole grains
Part used
Not applicable: an essential mineral
Key constituents
Elemental magnesium. The salt named on the label determines how much elemental magnesium a capsule actually provides and how well it is tolerated
Classification
Essential mineral and enzyme cofactor
Traditional use
Magnesium salts have a long history of use as laxatives and antacids
US regulatory status
Dietary supplement; some magnesium salts are also regulated as over-the-counter laxatives and antacids

Human evidence, outcome by outcome

Graded per outcome. A strong result for one outcome says nothing about another.

Blood pressure in hypertensive people on medication, or people with low blood magnesium

Limited human evidence

Systolic blood pressure fell by 7.68 mmHg in hypertensive people taking blood-pressure medication and by 5.97 mmHg in those with low blood magnesium, against an overall average of 2.81 mmHg 1.

Studied: 38 randomized trials, 2,709 participants, elemental magnesium from 82 to 637 mg daily with a median of 365 mg, median duration 12 weeks.

Limits: Heterogeneity between trials was high and no dose-response relationship was identified, so the size of the effect is less settled than the direction 1.

Blood pressure in people who are not hypertensive

Evidence against

In normotensive groups the blood-pressure reduction did not reach statistical significance 1.

Studied: Subgroup analysis within the same 38 trials.

Limits: This is the deficit pattern that runs through the whole Lab: the effect appears where something is already wrong.

Preventing idiopathic and nocturnal leg cramps

Evidence against

Magnesium produced no statistically significant difference from placebo in cramp frequency, in the proportion of people achieving a 25% reduction, or in cramp intensity or duration 2.

Studied: A Cochrane review of 11 randomized trials in 735 people, with the idiopathic-cramp analyses largely in older adults.

Limits: This is the strongest negative result on the page. The frequency finding was moderate-certainty and the 25%-reduction finding high-certainty evidence, with minimal heterogeneity 2.

Falling asleep faster

Limited human evidence

Sleep onset latency was about 17 minutes shorter than placebo, while the gain in total sleep time was not statistically significant 3.

Studied: Three randomized placebo-controlled trials in 151 older adults with insomnia.

Limits: All three trials were at moderate-to-high risk of bias and the reviewers graded the evidence low to very low quality, concluding the literature is substandard for firm recommendations 3.

Cramps in pregnancy

Not established

The pregnancy trials could not be combined, and of three placebo-controlled studies one found no benefit, one found benefit and one reported results that could not be reconciled 2.

Studied: Five trials in 408 pregnant women, all judged at high risk of bias.

Limits: Genuinely unresolved rather than negative, and distinct from the idiopathic-cramp finding above.

The gap between what it is sold for and what it does

Magnesium is marketed most heavily for muscle cramps and sleep. Those are the two outcomes with the weakest support on this page: cramps has a high-certainty negative from Cochrane 2, and sleep rests on three small trials the reviewers themselves described as substandard 3.

Meanwhile the strongest result, blood pressure in hypertensive people and in those already low in magnesium 1, is rarely the reason anyone buys it.

Why the sleep evidence is still worth something

A weak positive is not the same as a negative. The reviewers who graded the magnesium sleep evidence as low quality still landed mildly in favour, and their reasoning is worth borrowing: magnesium is cheap, widely available and safe in ordinary amounts, so the cost of a weak positive turning out to be wrong is small 3.

That is a reasonable basis for trying it. It is not the same as evidence that it works, and the two should not be quoted interchangeably.

Forms and tolerability

The salt on the label matters for two reasons. It determines how much elemental magnesium a capsule contains, so comparing products by the number on the front without checking which figure is quoted produces misleading comparisons. It also determines gastrointestinal tolerability, which is why some magnesium salts are sold as laxatives in their own right.

Marketing claims about the superiority of specific forms generally run ahead of the comparative trial evidence.

How closely our product matches what was studied

MDS Labs sells Pure Magnesium Glycinate at 275 mg elemental. The blood-pressure trials used elemental doses from 82 to 637 mg daily with a median of 365 mg 1, so 275 mg sits inside the studied range and below its midpoint.

Two things are worth stating plainly against that. The blood-pressure effect concentrated in people who were already hypertensive or low in magnesium, and did not reach significance in normotensive groups 1. And for the nocturnal leg cramps magnesium is most often bought to treat, the Cochrane review found no benefit 2.

We sell it because the published research on the compound is worth following, which is a different statement from a claim about what it will do for you.

What we can conclude

If you are hypertensive, on blood-pressure medication, or have been found to be low in magnesium, this is a supplement with a real and reasonably well-measured effect 1. If you are buying it for nocturnal leg cramps, the best available evidence says it will not help 2. If you are buying it to fall asleep faster, the evidence is weak but the risk is low, which is a defensible reason to run your own trial rather than a reason to expect much.

Technical layer: chemistry and pharmacokinetics

Measurement. Serum magnesium is the routinely available test, but most body magnesium is intracellular and in bone, so a normal serum value does not exclude depletion. This is why the blood-pressure subgroup finding in people with documented low magnesium is informative while a general population result is harder to interpret 1.

Dose range in the trials. The blood-pressure analysis covered elemental doses from 82 to 637 mg daily with a median of 365 mg over a median of 12 weeks 1. The sleep trials used quantities under 1 g of magnesium salt given up to three times daily 3.

Interactions. Magnesium salts can interfere with the absorption of several medicines, including some antibiotics, and magnesium handling changes in kidney impairment. Both are reasons to involve a pharmacist rather than to assume a mineral is inert.

References

  1. Argeros Z, Xu X, Bhandari B, et al.. Magnesium Supplementation and Blood Pressure: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Hypertension 82(11):1844-1856, 2025. PMID 41000008.Supports: Meta-analysis of 38 randomized trials in 2,709 participants, elemental magnesium 82 to 637 mg daily (median 365 mg) for a median of 12 weeks: systolic blood pressure fell 2.81 mmHg and diastolic 2.05 mmHg overall, with much larger systolic reductions in hypertensive people on blood-pressure medication (-7.68 mmHg) and in people with low blood magnesium (-5.97 mmHg). No significant effect was reached in normotensive groups, and heterogeneity was high.
  2. Garrison SR, Korownyk CS, Kolber MR, et al.. Magnesium for skeletal muscle cramps. Cochrane Database Syst Rev 9(9):CD009402, 2020. PMID 32956536.Supports: Cochrane review of 11 randomized trials in 735 people: for idiopathic cramps, largely nocturnal leg cramps in older adults, magnesium showed no statistically significant difference from placebo in cramp frequency (-0.18 cramps per week at four weeks, moderate-certainty evidence), nor in the proportion achieving a 25% reduction (high-certainty evidence), nor in cramp intensity or duration. Pregnancy trials were at high risk of bias and gave conflicting results.
  3. Mah J, Pitre T. Oral magnesium supplementation for insomnia in older adults: a Systematic Review & Meta-Analysis. BMC Complement Med Ther 21(1):125, 2021. PMID 33865376.Supports: Meta-analysis of three randomized placebo-controlled trials in 151 older adults with insomnia: sleep onset latency was 17.36 minutes shorter with oral magnesium (95% CI -27.27 to -7.44, p = 0.0006), while the 16.06-minute gain in total sleep time was not statistically significant. All trials were at moderate-to-high risk of bias and the evidence was graded low to very low quality.

Disclosure. The Evidence Lab is published by MDS Labs, which sells dietary supplements. Lab pages do not link to products, and product pages do not cite the Lab as proof. How we handle this.

Back to Top
Added to cart
Your Cart
0
Close

No products in the cart.